• Users Online: 998
  • Home
  • Print this page
  • Email this page

    Article Cited by others


Impact of highly active antiretroviral therapy on ophthalmic manifestations in human immunodeficiency virus / acquired immune deficiency syndrome

Venkatesh Kartik K, Biswas J, Kumarasamy N

Year : 2008| Volume: 56| Issue : 5 | Page no: 391-393

   This article has been cited by
1 Endocannabinoids affect innate immunity of Muller glia during HIV-1 Tat cytotoxicity
Gopinath Krishnan,Nivedita Chatterjee
Molecular and Cellular Neuroscience. 2014; 59: 10
[Pubmed]  [Google Scholar] [DOI]
2 Ocular manifestation of HIV/AIDS and correlation with CD4+ cells count among adult HIV/AIDS patients in Jimma town, Ethiopia: a cross sectional study
Sisay Bekele,Yeshigeta Gelaw,Fasil Tessema
BMC Ophthalmology. 2013; 13(1): 20
[Pubmed]  [Google Scholar] [DOI]
3 Bilateral Microbial Keratitis in Highly Active Antiretroviral Therapy-induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Case Series
Ritika Sachdev, Shubha Bansal, Rajesh Sinha, Namrata Sharma, Jeewan S. Titiyal
Ocular Immunology and Inflammation. 2011; : 1
[HTML Full text]  [Google Scholar] [DOI]
4 HIV-1 Tat-Mediated Neurotoxicity in Retinal Cells
Nivedita Chatterjee, Shannon Callen, Gail M. Seigel, Shilpa J. Buch
Journal of Neuroimmune Pharmacology. 2011;
[HTML Full text]  [Google Scholar] [DOI]
5 The structure and functions of P-glycoprotein
Li, Y., Yuan, H., Yang, K., Xu, W., Tang, W., Li, X.
Current Medicinal Chemistry. 2010; 17(8): 786-800
[Pubmed]  [Google Scholar]
6 Human immunodeficiency virus and the ophthalmologist
Soman, R. and Purandare, B.
Indian Journal of Ophthalmology. 2008; 56(5): 355-356
[Pubmed]  [Google Scholar]


Read this article